Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 135

1.

Efficacy of Tadalafil Therapy and Changes in Oxidative Stress Levels in Male Patients with Lower Urinary Tract Symptoms and Overactive Bladder.

Matsuo T, Miyata Y, Araki K, Mukae Y, Otsubo A, Ohba K, Sakai H.

Low Urin Tract Symptoms. 2019 Aug 13. doi: 10.1111/luts.12283. [Epub ahead of print]

PMID:
31407871
2.

Periodontal Disease in Patients Receiving Dialysis.

Miyata Y, Obata Y, Mochizuki Y, Kitamura M, Mitsunari K, Matsuo T, Ohba K, Mukae H, Nishino T, Yoshimura A, Sakai H.

Int J Mol Sci. 2019 Aug 3;20(15). pii: E3805. doi: 10.3390/ijms20153805. Review.

3.

Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation.

Kitamura M, Mochizuki Y, Miyata Y, Obata Y, Mitsunari K, Matsuo T, Ohba K, Mukae H, Yoshimura A, Nishino T, Sakai H.

Int J Mol Sci. 2019 Jul 11;20(14). pii: E3413. doi: 10.3390/ijms20143413. Review.

4.

Stage-specific embryonic antigen-4 is a histological marker reflecting the malignant behavior of prostate cancer.

Nakamura Y, Miyata Y, Matsuo T, Shida Y, Hakariya T, Ohba K, Taima T, Ito A, Suda T, Hakomori SI, Saito S, Sakai H.

Glycoconj J. 2019 Jun 26. doi: 10.1007/s10719-019-09882-2. [Epub ahead of print]

PMID:
31243630
5.

A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer.

Hayashida Y, Miyata Y, Matsuo T, Ohba K, Sakai H, Taba M, Naito S, Taniguchi K.

BMC Urol. 2019 Jun 24;19(1):56. doi: 10.1186/s12894-019-0486-0.

6.

A Review of Oxidative Stress and Urinary Dysfunction Caused by Bladder Outlet Obstruction and Treatments Using Antioxidants.

Miyata Y, Matsuo T, Mitsunari K, Asai A, Ohba K, Sakai H.

Antioxidants (Basel). 2019 May 15;8(5). pii: E132. doi: 10.3390/antiox8050132. Review.

7.

The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-peptide in Bladder Cancer.

Nakamura Y, Miyata Y, Takehara K, Asai A, Mitsunari K, Araki K, Matsuo T, Ohba K, Sakai H.

Anticancer Res. 2019 May;39(5):2317-2324. doi: 10.21873/anticanres.13348.

PMID:
31092423
8.

[A Case of Giant Adrenal Endothelial Cyst that was Discovered in Pregnancy and Caused Bleeding Three Years Later].

Araki K, Hakariya T, Shida Y, Miyata Y, Tabata K, Abe K, Fukuoka J, Sakai H.

Hinyokika Kiyo. 2019 Jan;65(1):7-11. doi: 10.14989/ActaUrolJap_65_1_7. Japanese.

PMID:
30831671
9.

Effect of salt intake reduction on nocturia in patients with excessive salt intake.

Matsuo T, Miyata Y, Sakai H.

Neurourol Urodyn. 2019 Mar;38(3):927-933. doi: 10.1002/nau.23929. Epub 2019 Feb 1.

PMID:
30706965
10.

Editorial Comment from Dr Miyata et al. to Impact of serum sodium concentration on survival outcomes in patients with invasive bladder cancer without metastasis treated by cystectomy.

Miyata Y, Matsuo T, Sakai H.

Int J Urol. 2019 Mar;26(3):432. doi: 10.1111/iju.13893. Epub 2019 Jan 22. No abstract available.

PMID:
30669187
11.

Anti-Cancer Effects of Green Tea Polyphenols Against Prostate Cancer.

Miyata Y, Shida Y, Hakariya T, Sakai H.

Molecules. 2019 Jan 7;24(1). pii: E193. doi: 10.3390/molecules24010193. Review.

12.

Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Araki K, Miyata Y, Ohba K, Nakamura Y, Matsuo T, Mochizuki Y, Sakai H.

Medicines (Basel). 2018 Dec 20;6(1). pii: E2. doi: 10.3390/medicines6010002.

13.

Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies.

Miyata Y, Sakai H.

Int J Mol Sci. 2018 Oct 21;19(10). pii: E3270. doi: 10.3390/ijms19103270. Review.

14.

Selective, sensitive and comprehensive detection of immune complex antigens by immune complexome analysis with papain-digestion and elution.

Aibara N, Kamohara C, Chauhan AK, Kishikawa N, Miyata Y, Nakashima M, Kuroda N, Ohyama K.

J Immunol Methods. 2018 Oct;461:85-90. doi: 10.1016/j.jim.2018.06.021. Epub 2018 Jul 3.

PMID:
30158077
15.

Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer.

Miyata Y, Matsuo T, Araki K, Nakamura Y, Sagara Y, Ohba K, Sakai H.

Medicines (Basel). 2018 Aug 10;5(3). pii: E87. doi: 10.3390/medicines5030087. Review.

16.

High Consumption of Green Tea Suppresses Urinary Tract Recurrence of Urothelial Cancer via Down-regulation of Human Antigen-R Expression in Never Smokers.

Yasuda T, Miyata Y, Nakamura Y, Sagara Y, Matsuo T, Ohba K, Sakai H.

In Vivo. 2018 Jul-Aug;32(4):721-729. doi: 10.21873/invivo.11300.

17.

Pathological significance and prognostic roles of densities of CD57+ cells, CD68+ cells, and mast cells, and their ratios in clear cell renal cell carcinoma.

Nakanishi H, Miyata Y, Mochizuki Y, Yasuda T, Nakamura Y, Araki K, Sagara Y, Matsuo T, Ohba K, Sakai H.

Hum Pathol. 2018 Sep;79:102-108. doi: 10.1016/j.humpath.2018.05.007. Epub 2018 May 19.

18.

Influence of prior oral ethinylestradiol use on the efficacy of enzalutamide for the treatment of castration-resistant prostate cancer in men.

Hakariya T, Shida Y, Tsurusaki T, Watanabe J, Furukawa M, Matsuya F, Miyata Y, Sakai H.

Int J Urol. 2018 May;25(5):464-470. doi: 10.1111/iju.13542. Epub 2018 Mar 8.

19.

Expression of Class III Beta-tubulin Predicts Prognosis in Patients with Cisplatin-resistant Bladder Cancer Receiving Paclitaxel-based Second-line Chemotherapy.

Miyata Y, Matsuo T, Nakamura Y, Yasuda T, Ohba K, Takehara K, Sakai H.

Anticancer Res. 2018 Mar;38(3):1629-1635.

PMID:
29491095
20.

Immune complexome analysis of antigens in circulating immune complexes from patients with acute cellular rejection after living donor liver transplantation.

Aibara N, Ohyama K, Hidaka M, Kishikawa N, Miyata Y, Takatsuki M, Eguchi S, Kuroda N.

Transpl Immunol. 2018 Jun;48:60-64. doi: 10.1016/j.trim.2018.02.011. Epub 2018 Mar 2.

PMID:
29477751

Supplemental Content

Loading ...
Support Center